![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Electrocore’s gammaCore Vagus Nerve Stimulator an FDA Breakthrough Device
Electrocore’s gammaCore Vagus Nerve Stimulator an FDA Breakthrough Device
The FDA has granted ElectroCore’s gammaCore noninvasive vagus nerve stimulator (nVNS) a Breakthrough Device designation.
The device, which is designed to treat posttraumatic stress disorder (PTSD), reduced symptoms in a clinical trial by 31 percent when compared to placebo, according to the Rockaway, N.J.-based company.
The study data also showed that the stimulation blocks sympathetic nervous system and inflammatory responses to memories of traumatic events in PTSD patients.
Upcoming Events
-
27Jun
-
11Jul
-
18Jul
-
21Oct